QT Imaging Taps Top Breast Cancer Specialist as Medical Advisor
Event summary
- QT Imaging named Dr. Mary Yamashita, a breast cancer researcher and USC Keck School of Medicine faculty, as its Medical Advisor on March 4, 2026.
- Dr. Yamashita will guide clinical integration, structured reporting, and training for QT Imaging's radiation-free breast imaging technology.
- She brings experience from leading breast imaging divisions at USC and multicenter clinical trials of advanced imaging technologies.
- QT Imaging aims to leverage her expertise to optimize its Breast Acoustic CT™ Scanner and accelerate adoption of best-in-class reporting practices.
The big picture
QT Imaging's appointment of Dr. Yamashita underscores its push to solidify clinical credibility in the competitive breast imaging market. The move comes as demand grows for safer, more accurate screening solutions, particularly for patients with dense breast tissue. With her academic and clinical leadership, Dr. Yamashita could help QT Imaging navigate regulatory hurdles and accelerate product adoption, positioning the company as a key player in the shift toward radiation-free diagnostics.
What we're watching
- Clinical Validation
- How Dr. Yamashita's guidance will impact the scientific foundation and regulatory approval path for QT Imaging's technology.
- Market Differentiation
- Whether QT Imaging can sustain its competitive edge in radiation-free breast imaging through structured reporting advancements.
- Adoption Pace
- The pace at which QT Imaging can expand access to its technology across diverse care settings with Dr. Yamashita's clinical leadership.